As a primary component in ECM, HA or LMW-HA can be recognized by various types of cells including cancer cells through HA receptors (such as CD44, RHAMM, etc), thereby playing pivotal roles in many biological processes such as tumor invasion, proliferation, and inflammation [61]. Here, CD44 is linked to cancer.